Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5

Bioconjugate Chemistry

Volumn 11, Issue 3, 2000, Pages 327-334

  Tsai, S W ^a   Sun, Y Y ^a   Williams, L E ^a   Raubitschek, A A ^a   Wu, A M ^a   Shively, J E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CELL CULTURE; CHELATION; DIAGNOSIS; DISEASES; EPITOPES; MAMMALS; MONOCLONAL ANTIBODIES;

% REDUCTIONS; BIODISTRIBUTIONS; BREAST CANCER XENOGRAFTS; GROWTH INHIBITION; HUMAN BREAST CANCER; NUDE MICE; RADIOIMMUNOTHERAPY; TRANS-MEMBRANE PROTEINS; TUMOR GROWTH; UNTREATED CONTROL;

TUMORS;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 0034083274     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc9901292     Document Type: Article

References (41)

1. HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14, 737-744.
2. HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol. 16, 2659-2671.
3. Valone, F. H., Kaufman, P. A., Guyre, P. M., Lewis, L. D., Memoli, V., Deo, Y., Graziano, R., Fisher, J. L., Meyer, L., and Mrozek-Orlowski, M. (1995) Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J. Clin. Oncol. 13, 2281-2292.
4. Bargmann, C. I., Hung, M.-C., and Weinberg, R. A. (1986) The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature 319, 226-230.
5. Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeberg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., Levison, A., and Ulrich, A. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230, 1132-1139.
6. Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., and Weinberg, R. A. (1984) The neu oncogene: an erb-B related gene encoding a 185,-000 Mr tumor antigen. Nature 312, 513-516.
7. Iglehart, J. D., Kraus, M. H., Langton, B. C., Huper, G., Kerns, B. J., and Marks, J. R. (1990) Increased erb B-2 gene copies and expression in mulitple stages of breast cancer. Cancer Res. 50, 6701-6707.
8. King, C. R., Kraus, M. H., and Aaronson, S. A. (1985) Amplification of a novel v-erb B-related gene in a human mammary carcinoma. Science 229, 974-976.
9. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ulrich, A., and Press, M. F. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712.
10. Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ulrich, A., and McGuire, W. L. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182.
11. Drebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., and Greene, M. I. (1985) Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies. Cell 41, 695-706.
12. Drebin, J. A., Link, V. C., Weinberg, R. A., and Greene, M. I. (1986) Inhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigen. Proc. Natl. Acad. Sci. U.S.A. 83, 9129-9133.
13. Hancock, M. C., Langton, B. C., Chan, T., Toy, P., Monahan, J. J., Mischak, R. P., and Shawver, L. K. (1991) A monoclonal antibody against the c-erb B-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian cell lines. Cancer Res. 51, 4575-4580.
14. Hudziak, R. M., Lewis, G. D., Winget, M., Fendly, B. M., Shepard, H. M., and Ulrich, A. (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro, and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell Biol. 9, 1165-1172.
15. HER2 monoclonal antibodies. Cancer Immunol. Immunother. 37, 255-263.
16. Stancovski, I., Hurwitz, E., Leitner, O., Ulrich, A., Yarden, Y., and Sela, M. (1991) Mechanistic aspects of the opposing effects of monoclonal antibodies to the erbB-2 receptor on tumor growth. Proc. Natl. Acad. Sci. U.S.A. 88, 8691-8695.
17. Arteaga, C. L., Winnier, A. R., Poirier, M. C., Lopez-Larraza, D. M., Shawver, L. K., Hurd, S. D., and Stewart, S. J. (1994) p185c-erbB-2 signal enhances cisplatin induced cytoxicity in human breast carcinoma cells: association between an oncogenic tyrosine kinase and drug-induced DNA repair. Cancer Res. 54, 3758-3765.
18. Pietras, R. J., Fendly, B. M., Chazin, V. R., Pegram, M. D., Howell, S. B., and Slamon, D. J. (1994) Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene 9, 1829-1838.
19. HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 89, 4285-4289.
20. De Santes, K., Slamon, D., Anderson, S. K., Shepard, M., Fendly, B., Maneval, D., and Press, O. (1992) Radiolabeled antibody targeting of the HER-2/neu oncoprotein. Cancer Res. 52, 1916-1923.
21. DeNardo, S. J., DeNardo, G. L., Kukis, D. L., Shen, S., Kroger, L. A., DeNardo, D. A., Goldstein, D. S., Mirick, G. R., Salako, Q., Mausner, L. F., Srivastava, S. C., and Meares, C. F. (1999) 67Cu-2IT-BAT-Lym-1 pharmacokinetics, radiation dosimetry, toxicity, and tumor regression in patients with lymphoma. J. Nucl. Med. 40, 302-310.
22. Wong, J. Y., Williams, L. E., Yamauchi, D. M., Odom-Maryon, L., Esteban, J. M., Neumaier, M., Wu, A. M., Johnson, D. K., Primus, F. J., Shively, J. E., and Raubitschek, A. A. (1995) Initial experience evaluating 90-yttrium radio-labeled anti-CEA chimeric T84.66 in a phase I radioimmunotherapy trial. Cancer Res. 55, 5929s-5934s.
23. DeNardo, S. J., Kramer, E. L., O'Donnell, R. T., Richman, C. M., Salako, Q. A., Shen, S., Noz, M., Glenn, S. D., Ceriani, R. L., and DeNardo, G. L. (1997) Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial. J. Nucl. Med. 38, 1180-1185.
24. Brechbiel, M. W., Gransow, O. A., Atcher, R. W., Schlom, J., Esteban, J., Simpson, D. E., and Colcher, D. (1986) Synthesis of 1-(p-Isothiocyanatobenzyl) derivatives of DTPA and EDTA. antibody labeling and tumor-imaging studies. Inorg. Chem. 25, 2772-2781.
25. Lewis, M. R., Raubitschek, A., and Shively, J. E. (1994) A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immunoconjugates. Bioconjugate Chem. 5, 565-576.
26. 111Indium-DOTA chelates: A simple and efficient method. Bioconjugate Chem. 5, 101-104.
27. Horak, E., Hartmann, F., Garmestani, K., Wu, C., Brechbiel, M., Gansow, O. A., Landolfi, N. F., and Waldmann, T. A. (1997) Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using Lead-212-DOTA-AE1. J. Nuclear Med. 38, 1944-1950.
28. Meares, C. F., McCall, M. J., Reardan, D. T., Goodwin, D. A., Diamanti, C. I., and McTigue, M. (1984) Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, Methods of Analysis, and Subsequent Addition of Metal Ions. Anal. Biochem. 142, 68-78.
29. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P. A., Jr. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immun. Methods 72, 77-89.
30. Hsu, S. M., Raine, L., and Fanger, H. (1981) Use of avidinbiotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
31. Pietras, R. J., Poen, J. C., Gallardo, D., Wongvipat, P. N., Lee, H. J., and Slamon, D. J. (1999) Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res. 15, 1347-1355.
32. Fendly, B. M., Winget, M., Hudziak, R. M., Lipari, M. T., Napier, M. A., and Ulrich, A. (1990) Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res. 50, 1550-1558.
33. Pietras, R. J., Pegram, M. D., Finn, R. S., Maneval, D. A., and Slamon, D. J. (1998) Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs. Oncogene 17, 2235-2249.
34. 111In. Cancer Res. 47, 1149-1154.
35. Schott, M. E., Milenic, D. E., Yakota, T., Whitlow, M., Wood, J. F., Fordyce, W. A., Cheng, R. C., and Schlom, J. (1992) Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. Cancer Res. 52, 6413-6417.
36. Sharkey, R. M., Blumenthal, R. D., Behr, T. M., Wong, G. Y., Haywood, L., Forman, D., Griffiths, G. L., and Goldenberg, D. M. (1997) Selection of radioimmunoconjugates for the therapy of well established or micrometastatic colon carcinoma. Int. J. Cancer 72, 477-485.
37. Stein, R., Chen, S., Haim, S., and Goldenberg, D. M. (1997) Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft. Cancer 80, 2636-2641.
38. 90Y antibody therapy of colon cancer xenografts in nude mice. Cancer Res. (Suppl.) 50, 1008s-1010s.
39. Baselga, J., Norton, L., Albanell, J., Kim, Y., and Mendelsohn, J. (1998) Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of Paclitaxel and Doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res. 58, 2825-2831.
40. Novak-Hofer, I., Amstutz, H. P., Macke, H. R., Schwartzbach, R., Zimmermann, K., Morgenthaler, J., and Schubiger, P. A. (1995) Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells. Cancer Res. 55, 46-50.
41. Press, O. W., Shan, D., Howell-Clark, J., Eary, J., Appelbaum, F. R., Matthews, D., King, D. J., Haines, A., Hamann, P., Hinman, L., Shochat, D., and Bernstein, I. D. (1996) Comparative metabolism and retention of Iodine-125, Yt-trium-90, and Indium-111 radioimmunoconjugates by cancer cells. Cancer Res. 56, 2123-2129.